View in EDS HTML Full Text PDF Full Text

Anti-CD20-atezolizumab-polatuzumab vedotin in relapsed/refractory follicular and diffuse large B-cell lymphoma.

Saved in:
Bibliographic Details
Title: Anti-CD20-atezolizumab-polatuzumab vedotin in relapsed/refractory follicular and diffuse large B-cell lymphoma.
Authors: Topp MS; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Anstalt des öffentlichen Rechts, Josef-Schneider-Straße 2, 97080, Würzburg, Germany. topp_m@ukw.de., Eradat H; Division of Hematology-Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Florschütz A; Städtisches Klinikum Dessau, Dessau-Roβlau, Germany., Hochhaus A; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany., Wrobel T; Department of Hematology, Wrocław Medical University, Wrocław, Poland., Walewski J; Narodowy Instytut Onkologii im, Marii Skłodowskiej-Curie - Panstwowy Instytut Badawczy, Warsaw, Poland., Knopinska-Posluszny W; Uniwersytet Warmińsko-Mazurski, Olsztynie, Poland., Kanate AS; West Virginia University Cancer Institute, Morgantown, WV, USA., Lech-Maranda E; Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Brunnberg U; Universitätsklinikum Frankfurt, Frankfurt, Germany., Chitra S; Genentech, Inc., South San Francisco, CA, USA., Nielsen TG; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Sellam G; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Shivhare M; Roche Products Limited, Welwyn Garden City, UK., Lossos IS; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
Source: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Feb; Vol. 149 (2), pp. 811-817. Date of Electronic Publication: 2022 Feb 18.
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35182224
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Anti-CD20-atezolizumab-polatuzumab vedotin in relapsed/refractory follicular and diffuse large B-cell lymphoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Topp+MS%22">Topp MS</searchLink>; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Anstalt des öffentlichen Rechts, Josef-Schneider-Straße 2, 97080, Würzburg, Germany. topp_m@ukw.de.<br /><searchLink fieldCode="AU" term="%22Eradat+H%22">Eradat H</searchLink>; Division of Hematology-Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Florschütz+A%22">Florschütz A</searchLink>; Städtisches Klinikum Dessau, Dessau-Roβlau, Germany.<br /><searchLink fieldCode="AU" term="%22Hochhaus+A%22">Hochhaus A</searchLink>; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.<br /><searchLink fieldCode="AU" term="%22Wrobel+T%22">Wrobel T</searchLink>; Department of Hematology, Wrocław Medical University, Wrocław, Poland.<br /><searchLink fieldCode="AU" term="%22Walewski+J%22">Walewski J</searchLink>; Narodowy Instytut Onkologii im, Marii Skłodowskiej-Curie - Panstwowy Instytut Badawczy, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Knopinska-Posluszny+W%22">Knopinska-Posluszny W</searchLink>; Uniwersytet Warmińsko-Mazurski, Olsztynie, Poland.<br /><searchLink fieldCode="AU" term="%22Kanate+AS%22">Kanate AS</searchLink>; West Virginia University Cancer Institute, Morgantown, WV, USA.<br /><searchLink fieldCode="AU" term="%22Lech-Maranda+E%22">Lech-Maranda E</searchLink>; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Brunnberg+U%22">Brunnberg U</searchLink>; Universitätsklinikum Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Chitra+S%22">Chitra S</searchLink>; Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Nielsen+TG%22">Nielsen TG</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sellam+G%22">Sellam G</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Shivhare+M%22">Shivhare M</searchLink>; Roche Products Limited, Welwyn Garden City, UK.<br /><searchLink fieldCode="AU" term="%22Lossos+IS%22">Lossos IS</searchLink>; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227902060%22">Journal of cancer research and clinical oncology</searchLink> [J Cancer Res Clin Oncol] 2023 Feb; Vol. 149 (2), pp. 811-817. <i>Date of Electronic Publication: </i>2022 Feb 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag%22">Springer-Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7902060 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-1335 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201715216%22">01715216 </searchLink><i>NLM ISO Abbreviation: </i>J Cancer Res Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35182224
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00432-021-03847-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 811
    Titles:
      – TitleFull: Anti-CD20-atezolizumab-polatuzumab vedotin in relapsed/refractory follicular and diffuse large B-cell lymphoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Topp MS
      – PersonEntity:
          Name:
            NameFull: Eradat H
      – PersonEntity:
          Name:
            NameFull: Florschütz A
      – PersonEntity:
          Name:
            NameFull: Hochhaus A
      – PersonEntity:
          Name:
            NameFull: Wrobel T
      – PersonEntity:
          Name:
            NameFull: Walewski J
      – PersonEntity:
          Name:
            NameFull: Knopinska-Posluszny W
      – PersonEntity:
          Name:
            NameFull: Kanate AS
      – PersonEntity:
          Name:
            NameFull: Lech-Maranda E
      – PersonEntity:
          Name:
            NameFull: Brunnberg U
      – PersonEntity:
          Name:
            NameFull: Chitra S
      – PersonEntity:
          Name:
            NameFull: Nielsen TG
      – PersonEntity:
          Name:
            NameFull: Sellam G
      – PersonEntity:
          Name:
            NameFull: Shivhare M
      – PersonEntity:
          Name:
            NameFull: Lossos IS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2023 Feb
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1432-1335
          Numbering:
            – Type: volume
              Value: 149
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal of cancer research and clinical oncology
              Type: main
ResultId 1